-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Anika Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Anika Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$29.9M, a 355% decline year-over-year.
- Anika Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$97.5M, a 297% decline year-over-year.
- Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$82.7M, a 456% decline from 2022.
- Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 459% decline from 2021.
- Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $4.13M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)